Osamu Nagai

Director/Board Member at IFIS JAPAN LTD.

71 year

Health Technology

Finance

Technology Services

Profile

Osamu Nagai is an Independent Director at IFIS Japan Ltd.
since 2021.
He was an Executive Director at Fujisawa Pharmaceutical Co., Ltd.
from 2000 to 2003 and an Executive Officer at Sanwa Bank Ltd.
from 1973 to 1997.
He also served as a Corporate Auditor at Astellas Pharma, Inc.

Osamu Nagai active positions

Companies	Position	Start
IFIS JAPAN LTD.	Director/Board Member	25/03/2021

All active positions of Osamu Nagai

Former positions of Osamu Nagai

Companies	Position	End
Fujisawa Pharmaceutical Co., Ltd. Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP	Director/Board Member	31/03/2003
Sanwa Bank Ltd.	Corporate Officer/Principal	31/12/1996
ASTELLAS PHARMA INC.	Comptroller/Controller/Auditor	-

See the detail of Osamu Nagai's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Osamu Nagai's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
ASTELLAS PHARMA INC.	Health Technology
IFIS JAPAN LTD.	Technology Services

Private companies	2
Fujisawa Pharmaceutical Co., Ltd. Fujisawa Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Fujisawa Pharmaceutical Co. Ltd. develops, manufactures and markets pharmaceuticals and medical products. The Group's principal activity is the manufacture and sale of pharmaceuticals, medical equipment and supplies, home care products, chemicals and animal health products. Pharmaceuticals (ethical drugs, OTC drugs, toilet goods) accounted for 91% of fiscal 2002 revenues and other operations (food additives, industrial chemicals, animal drugs, research and clinical reagents). It was founded in 1894 and was headquartered in Osaka, JP	Health Technology
Sanwa Bank Ltd.	Finance